{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:39:06Z","timestamp":1790829546702,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Africa is a unique continent due to high disease burden for both communicable and non-communicable diseases, attracting large-scale distribution of medicines to tackle public health issues. This poses several challenges for the healthcare systems, particularly concerning the circulation of substandard and falsified medicines. The widespread of substandard and falsified medicines causes adverse health effects on patients and contributes to millions of deaths annually. This review explores how health systems in Africa, supply chain issues and regulatory environment affect the circulation of substandard and falsified medicines. A narrative review was conducted drawing information from academic publication, official reports and other grey literature between January 2014 and October 2025 focusing on substandard and falsified medicines, health systems, supply chain and regulatory issues in Africa. Health system challenges in Africa include uneven geographical distribution of health facilities, medicines stockouts, increased costs of medicines purchased from private healthcare facilities and inadequate health financing. These factors increase out-of-pocket expenditure on patients and drive the poor majority of Africans to source cheaper medicines from unregulated markets, thereby increasing the likelihood of consuming substandard and falsified medicines. Supply chain issues include a lack of industrialisation to meet the medicine demand, a lack of support to local logisticians, poor forecasting, and over-dependence on imports, complicating the supply of quality medicines. The complexity of the supply chain system creates numerous opportunities to disrupt the supply of quality and safe medicines, making it easy for substandard and falsified medicines to reach the patient. Medicines regulation in Africa also suffers several challenges including limited well-functioning regulatory systems, inadequate staffing levels and a lack of analytical technologies for fast screening of substandard and falsified medicines. The review further provides recommendations and priority areas that should be considered to strengthen health systems, supply chains and regulation of medicines in Africa to reduce the prevalence of substandard and falsified on the continent.<\/jats:p>","DOI":"10.3389\/fphar.2025.1708784","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:12:41Z","timestamp":1763442761000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines"],"prefix":"10.3389","volume":"16","author":[{"given":"Billy","family":"Chabalenge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarsem","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Ermolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/pharmacy7040167","article-title":"Sub-standard pharmaceutical services in private healthcare facilities serving low-income settlements in Nairobi county, Kenya","volume":"7","author":"Abuga","year":"2019","journal-title":"Pharmacy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1002\/puh2.9","article-title":"Revisiting the issue of access to medicines in Africa: challenges and recommendations","volume":"1","author":"Adebisi","year":"2022","journal-title":"Public Health Challenges"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23992026211070406","DOI":"10.1177\/23992026211070406","article-title":"Tackling the global impact of substandard and falsified and unregistered\/unlicensed anti-tuberculosis medicines","volume":"6","author":"Akpobolokemi","year":"2022","journal-title":"J. Med. Access"},{"key":"B4","doi-asserted-by":"publisher","first-page":"maapoc.0000023","DOI":"10.5301\/maapoc.0000023","article-title":"Unveiling the peril of substandard and falsified medicines to public health and safety in Africa: need for all-out war to end the menace","volume":"1","author":"Aminu","year":"2017","journal-title":"Med. Access Point Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103405","DOI":"10.1016\/j.eclinm.2025.103405","article-title":"Quality of antidiabetic medicines in 13 sub-saharan African countries: a cross-sectional survey","volume":"87","author":"Antignac","year":"2025","journal-title":"eClinicalMedicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2375267","DOI":"10.1080\/20523211.2024.2375267","article-title":"Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review","volume":"17","author":"Asrade Mekonnen","year":"2024","journal-title":"J. Pharm. Policy Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e000088","DOI":"10.1136\/bmjph-2023-000088","article-title":"Delivering maternal and child health interventions through the private sector in LMIC: a scoping review of strategies and effective approaches","volume":"1","author":"Awor","year":"2023","journal-title":"BMJ Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"113948","DOI":"10.1016\/j.jpba.2021.113948","article-title":"Current challenges in the detection and analysis of falsified medicines","volume":"197","author":"Bakker-\u2019t Hart","year":"2021","journal-title":"J. Pharm. Biomed. Analysis"},{"key":"B9","volume-title":"The localisation of medical manufacturing in Africa","author":"Banda","year":"2022"},{"key":"B10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40264-019-00898-z","article-title":"Comparative assessment of the national pharmacovigilance systems in East Africa: ethiopia, Kenya, Rwanda and Tanzania","volume":"43","author":"Barry","year":"2020","journal-title":"Drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0209641","DOI":"10.1371\/journal.pone.0209641","article-title":"A cross-sectional study to identify the distribution and characteristics of licensed and unlicensed private drug shops in rural eastern Uganda to inform an iCCM intervention to improve health outcomes for children under five years","volume":"14","author":"Buchner","year":"2019","journal-title":"PLOS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1379250","DOI":"10.3389\/fphar.2024.1379250","article-title":"Availability, pricing, and affordability of essential medicines for pediatric population in Malawi","volume":"15","author":"Chiumia","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jphs.12274","article-title":"Poor performance of medicines logistics and supply chain systems in a developing country context: lessons from Nigeria","volume":"9","author":"Chukwu","year":"2018","journal-title":"J. Pharm. Health Serv. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.37602\/ijssmr.2024.7304","article-title":"Motivations and obstacles for buying products on illicit markets","volume":"7","author":"Cl\u00e9mence","year":"2024","journal-title":"Int. J. Soc. Sci. Manag. Rev."},{"key":"B15","volume-title":"Should Sub-Saharan Africa make its own drugs?","author":"Conway","year":"2019"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40545-020-00255-x","article-title":"A rapid assessment of the national regulatory systems for medical products in the southern African development community","volume":"13","author":"Dube-Mwedzi","year":"2020","journal-title":"J. Pharm. Policy Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41120-019-0032-x","article-title":"Drug manufacturing and access to medicines: the West African story. A literature review of challenges and proposed remediation","volume":"5","author":"Ekeigwe","year":"2019","journal-title":"AAPS Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"31760","DOI":"10.1073\/pnas.2009172117","article-title":"Planning universal accessibility to public health care in Sub-Saharan Africa","volume":"117","author":"Falchetta","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12913-020-05435-8","article-title":"Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review","volume":"20","author":"Fanelli","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103118","DOI":"10.1016\/j.apgeog.2023.103118","article-title":"Estimating geographic access to healthcare facilities in Sub-Saharan Africa by degree of urbanisation","volume":"160","author":"Florio","year":"2023","journal-title":"Appl. Geogr."},{"key":"B21","unstructured":"Internet usage in Africa - Statistics and facts\n          \n          \n            \n              Galal\n              S.\n            \n          \n          \n          2024"},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4269\/ajtmh.14-0535","article-title":"Monitoring the quality of medicines: results from Africa, Asia, and South America","volume":"92","author":"Hajjou","year":"2015","journal-title":"Am. Soc. Trop. Med. Hyg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12939-024-02103-9","article-title":"The critical pharmaceutical situation in Sudan 2023: a humanitarian catastrophe of civil war","volume":"23","author":"Hemmeda","year":"2024","journal-title":"Int. J. Equity Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0220583","DOI":"10.1371\/journal.pone.0220583","article-title":"Effect of corruption on perceived difficulties in healthcare access in Sub-Saharan Africa","volume":"14","author":"Hsiao","year":"2019","journal-title":"PLOS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/23992026221074548","article-title":"A critical review on the availability of substandard and falsified medicines online: incidence, challenges and perspectives","volume":"6","author":"Jamee","year":"2022","journal-title":"J. Med. Access"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100302","DOI":"10.1016\/j.fsir.2022.100302","article-title":"Counterfeit and substandard drugs in Tanzania: a review","volume":"7","author":"Karungamye","year":"2023","journal-title":"Forensic Sci. Int. Rep."},{"key":"B27","unstructured":"Malawi continues to face acute drug shortages due to COVID-19\n          \n          \n            \n              Kateta\n              M. W.\n            \n          \n          \n          2022"},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15171\/ijhpm.2018.97","article-title":"Decentralisation and health services delivery in 4 districts in Tanzania: how and why does the use of decision space vary across districts?","volume":"8","author":"Kigume","year":"2019","journal-title":"Int. J. Health Policy Manag."},{"key":"B29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13643-022-02114-z","article-title":"Implementation of medicines pricing policies in Sub-Saharan Africa: systematic review","volume":"11","author":"Koduah","year":"2022","journal-title":"Syst. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e009367","DOI":"10.1136\/bmjgh-2022-009367","article-title":"Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in Sub-Saharan Africa","volume":"6","author":"Kusynov\u00e1","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0202059","DOI":"10.1371\/journal.pone.0202059","article-title":"Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy","volume":"13","author":"Lawson","year":"2018","journal-title":"PLOS ONE"},{"key":"B32","volume-title":"Health for everyone, everywhere? As service delivery falls short, Africans rank health as a top priority for government action","author":"Lionel","year":"2024"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.puhip.2020.100060","article-title":"Drug shortage crisis in Sudan in times of COVID-19","volume":"1","author":"Lucero-Prisno","year":"2020","journal-title":"Public Health Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"622862","DOI":"10.3389\/fphar.2020.622862","article-title":"Identifying and characterizing serious adverse drug reactions associated with drug-drug interactions in a spontaneous reporting database","volume":"11","author":"Magro","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1429872","DOI":"10.3389\/fmed.2024.1429872","article-title":"The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review","volume":"11","author":"Melia","year":"2024","journal-title":"Front. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"624285","DOI":"10.3389\/fmed.2021.624285","article-title":"Standard survey data: insights into private sector utilization","volume":"8","author":"Montagu","year":"2021","journal-title":"Front. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1117439","DOI":"10.3389\/fmed.2023.1117439","article-title":"The domestication of the African union model law on medical products regulation: perceived benefits, enabling factors, and challenges","volume":"10","author":"Ncube","year":"2023","journal-title":"Front. Med."},{"key":"B38","volume-title":"Guideline for procurement and the management of the mobile authentication service MAS scheme in Nigeria","year":"2018"},{"key":"B39","volume-title":"Trade in counterfeit pharmaceutical products","year":"2020"},{"key":"B40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pharmacy7020040","article-title":"Medicine prices, availability, and affordability in private health facilities in low-income settlements in Nairobi county, Kenya","volume":"7","author":"Ongarora","year":"2019","journal-title":"Pharmacy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2478\/aphi-2022-0003","article-title":"A literature review on the global burden and impact of substandard and falsified medicine","volume":"2","author":"Popoola","year":"2022","journal-title":"Ann. Public Health Issues"},{"key":"B42","doi-asserted-by":"publisher","first-page":"964399","DOI":"10.3389\/fphar.2022.964399","article-title":"Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: a descriptive study","volume":"13","author":"Pozsgai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e001912","DOI":"10.1136\/bmjgh-2019-001912","article-title":"Addressing the challenges of regulatory systems strengthening in small states","volume":"5","author":"Preston","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e16287","DOI":"10.15252\/emmm.202216287","article-title":"Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives","volume":"14","author":"Saied","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4269\/ajtmh.22-0525","article-title":"Health, economic, and social impacts of substandard and falsified medicines in low-and middle-income countries: a systematic review of methodological approaches","volume":"109","author":"Salami","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"27550834241236598","DOI":"10.1177\/27550834241236598","article-title":"Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: scoping review","volume":"8","author":"Sorato","year":"2024","journal-title":"J. Med. Access"},{"key":"B47","unstructured":"SAHPRA signs MOU with Egyptian drug authority\n          \n          \n          2023"},{"key":"B48","volume-title":"Localization of pharmaceutical manufacturing in Sub-Saharan Africa","author":"Steele","year":"2024"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e012561","DOI":"10.1136\/bmjgh-2023-012561","article-title":"Quality and equity: a shared agenda for universal health coverage","volume":"8","author":"Stevens","year":"2023","journal-title":"Br. Med. J. Glob. Health"},{"key":"B50","volume-title":"Analytical chemistry for assessing medication adherence","author":"Tanna","year":"2016"},{"key":"B51","first-page":"131","article-title":"6 IR spectroscopic analytical tools in the fight against counterfeit medicines","volume-title":"Quantitative and qualitative determination technologies of counterfeit drugs","author":"Tanna","year":"2023"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0295956","DOI":"10.1371\/journal.pone.0295956","article-title":"Substandard and falsified antimicrobials in selected east African countries: a systematic review","volume":"19","author":"Tegegne","year":"2024","journal-title":"Plos one"},{"key":"B53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12992-022-00826-4","article-title":"What is the impact of intellectual property rules on access to medicines? A systematic review","volume":"18","author":"Tenni","year":"2022","journal-title":"Glob. Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jphsr\/rmaa016","article-title":"A comparison study between public and private healthcare sector medicine prices in South Africa","volume":"12","author":"Thaver","year":"2021","journal-title":"J. Pharm. Health Serv. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"o2472","DOI":"10.1136\/bmj.o2472","article-title":"WHO investigates cough syrups after deaths of 66 children in Gambia","volume":"379","author":"Thiagarajan","year":"2022","journal-title":"Bristish Med. J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/RMHP.S348816","article-title":"Patients access to medicines \u2013 a critical review of the healthcare system in Kenya","volume":"15","author":"Toroitich","year":"2022","journal-title":"Risk Manag. Healthc. Policy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1186\/s12889-024-20036-4","article-title":"Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya\u2019s pharmacovigilance database","volume":"24","author":"Toroitich","year":"2024","journal-title":"BMC Public Health"},{"key":"B58","volume-title":"Attracting pharmaceutical manufacturing to africa\u2019s special economic zones","year":""},{"key":"B59","volume-title":"Building the case for investment in local pharmaceutical production in Africa: a comprehensive framework for investment policymakers","year":""},{"key":"B60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/23288604.2019.1596050","article-title":"Improving supply chain for essential drugs in low-income countries: results from a large scale randomized experiment in Zambia","volume":"5","author":"Vledder","year":"2019","journal-title":"Health Syst. and Reform"},{"key":"B61","volume-title":"Definitions of substandard and falsified (SF) medical products","year":"2017"},{"key":"B62","volume-title":"WHO global surveillance and monitoring system for substandard and falsified medical products","year":""},{"key":"B63","volume-title":"A study on the public health and socioeconomic impact of substandard and falsified medical products","year":""},{"key":"B64","volume-title":"Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey","year":"2020"},{"key":"B65","unstructured":"WHO global benchmarking tool (GBT) for evaluation of national regulatory systems of medicines and vaccines\n          \n          \n          2021"},{"key":"B66","volume-title":"WHO list of prequalified medicines quality control laboratories","year":"2024"},{"key":"B67","volume-title":"List of national regulatory authorities (NRAs) operating at maturity level 3 (ML3) and maturity level 4 (ML4) (as benchmarked against WHO global benchmarking tool (GBT))","year":"2025"},{"key":"B68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/CEOR.S413546","article-title":"Challenges to the availability and affordability of essential medicines in African countries: a scoping review","volume":"15","author":"Yenet","year":"2023","journal-title":"Clin. Outcomes Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1708784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:12:46Z","timestamp":1763442766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1708784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":68,"alternative-id":["10.3389\/fphar.2025.1708784"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1708784","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1708784"}}